Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism (Q46593328)

23 December 2017

title

Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism (English)

1 reference

23 December 2017

author name string

Gudrun Caspar-Bell

series ordinal

1 reference

23 December 2017

Indu Dhar

series ordinal

1 reference

23 December 2017

Kailash Prasad

series ordinal

1 reference

23 December 2017

publication date

19 February 2016

1 reference

23 December 2017

Molecular and Cellular Biochemistry

published in

1 reference

23 December 2017

volume

414

1 reference

23 December 2017

issue

1-2

1 reference

23 December 2017

page(s)

171-178

1 reference

23 December 2017

Hyperthyroidism: a secondary cause of isolated systolic hypertension

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Oxidative stress in cold-induced hyperthyroid state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Selenium and the course of mild Graves' orbitopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Advanced glycosylation: chemistry, biology, and implications for diabetes and aging

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

21 January 2018

12 December 2020

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

The biology of the receptor for advanced glycation end products and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Association between acute-phase reactants and advanced glycation end products in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Advanced glycation end products: a Nephrologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

The Association of Thyroid Function with Cardiac Mass and Left Ventricular Hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-016-2669-2

Atrial fibrillation: a symptom treated as a disease?

21 January 2018

1 reference

12 December 2020

Signal-averaged P-wave duration and risk of paroxysmal atrial fibrillation in hyperthyroidism

1 reference

12 December 2020

Thyrotoxicosis presenting as unstable angina and ventricular tachycardia with normal coronary arteries

1 reference

12 December 2020

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease

1 reference

12 December 2020

Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2

1 reference

12 December 2020

[Effect of functional stimulators of the thyroid and excess iodine on xenotransplanted human tissue in patients with autoimmune thyroid diseases]

1 reference

12 December 2020

Selenium and the Thyroid: A Close-Knit Connection

1 reference

12 December 2020

Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes

1 reference

12 December 2020

The nature and prognosis of thyrotoxic heart disease

1 reference

12 December 2020

Proinflammatory cytokine levels in hyperthyroidism

1 reference

12 December 2020

Antioxidant agents in the treatment of Graves' ophthalmopathy

1 reference

12 December 2020

10.1007/S11010-016-2669-2

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017